Smallcapvoice.com, Inc.

MIAMI, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending June 30, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies. Progressive Care dispensed more than 67,000 prescriptions in Q2 2018, a 21.45% increase over Q2 2017, and 133,000 prescriptions for the six-month period ending June 30, a 23% increase over the same period in 2017. Pharmacy revenue for the six-month period ending June 30, 2018, was approximately $10.3 million, the largest six-month period in the Company’s history and an increase of 3.41%. Progressive Care’s total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 — an increase of 43.13%. The Company continues to generate positive cash flow from its operations, with positive operational cash flow of approximately $69,000 for the six-month period ending June 30, 2018.